T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Healthcare | 16.26% |
| 3 | Consumer Discretionary | 15.34% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Newell Brands
NWL
$2.63B
| $13.6M | ﹤0.01% |
614,655
-12,563
| -2% | -$321K |
|
|
EB
1377
DELISTED
Eventbrite
EB
| $13.5M | ﹤0.01% |
712,363
-33,917
| -5% | -$596K |
|
1378
Immunocore
IMCR
$1.73B
| $13.4M | ﹤0.01% |
362,026
-5,278
| -1% | -$178K |
|
1379
Western Union
WU
$2.3B
| $13.4M | ﹤0.01% |
663,588
-13,751
| -2% | -$304K |
|
1380
Molson Coors Class B
TAP
$7.9B
| $13.4M | ﹤0.01% |
288,297
-5,203
| -2% | -$254K |
|
1381
Recursion Pharmaceuticals
RXRX
$1.69B
| $13.4M | ﹤0.01% |
580,670
-2,415
| -0.4% | -$68.4K |
|
1382
Oil-Dri
ODC
$1.29B
| $13M | ﹤0.01% |
743,250
-48,566
| -6% | -$851K |
|
1383
Ambev
ABEV
$42.7B
| $13M | ﹤0.01% |
4,710,600
| – | – |
|
|
WHWK
1384
Whitehawk Therapeutics
WHWK
$256M
| $13M | ﹤0.01% |
465,599
+448,686
| +2,653% | +$13.7M |
|
1385
IPG Photonics
IPGP
$3.67B
| $13M | ﹤0.01% |
81,931
-1,000
| -1% | -$184K |
|
1386
ePlus
PLUS
$2.31B
| $12.9M | ﹤0.01% |
251,988
-930
| -0.4% | -$46K |
|
1387
DXC Technology
DXC
$1.73B
| $12.7M | ﹤0.01% |
378,934
-17,504
| -4% | -$663K |
|
1388
PVH
PVH
$3.75B
| $12.7M | ﹤0.01% |
123,893
-2,135
| -2% | -$230K |
|
|
DISCK
1389
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $12.7M | ﹤0.01% |
522,915
+54,055
| +12% | +$1.44M |
|
|
XM
1390
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $12.6M | ﹤0.01% |
295,741
+40,400
| +16% | +$1.71M |
|
|
VER
1391
DELISTED
VEREIT, Inc.
VER
| $12.6M | ﹤0.01% |
278,115
-173,701
| -38% | -$8.44M |
|
1392
Dell
DELL
$318B
| $12.5M | ﹤0.01% |
236,292
-461,886
| -66% | -$23M |
|
1393
Guidewire Software
GWRE
$14.7B
| $12.4M | ﹤0.01% |
104,441
+313
| +0.3% | +$36.1K |
|
1394
Regenxbio
RGNX
$697M
| $12.4M | ﹤0.01% |
294,945
+14,728
| +5% | +$530K |
|
1395
Prelude Therapeutics
PRLD
$433M
| $12.4M | ﹤0.01% |
395,276
-5,526
| -1% | -$179K |
|
1396
Cheniere Energy
LNG
$56B
| $12.2M | ﹤0.01% |
125,165
+6,645
| +6% | +$582K |
|
|
UMH
1397
UMH Properties
UMH
$1.41B
| $11.7M | ﹤0.01% |
512,351
+485,125
| +1,782% | +$11.3M |
|
|
PBCT
1398
DELISTED
People's United Financial Inc
PBCT
| $11.6M | ﹤0.01% |
665,764
-12,280
| -2% | -$200K |
|
1399
Genpact
G
$5.71B
| $11.6M | ﹤0.01% |
243,532
-35,443
| -13% | -$1.76M |
|
|
GTM
1400
ZoomInfo Technologies
GTM
$1.21B
| $11.3M | ﹤0.01% |
185,256
+70,310
| +61% | +$4.21M |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.